SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-23-028579
Filing Date
2023-04-10
Accepted
2023-04-10 16:01:20
Documents
3
Period of Report
2023-04-10

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea176368-pre14a_jasper.htm PRE 14A 573263
2 GRAPHIC image_001.jpg GRAPHIC 213362
3 GRAPHIC image_002.jpg GRAPHIC 207116
  Complete submission text file 0001213900-23-028579.txt   1153703
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39138 | Film No.: 23811122
SIC: 2836 Biological Products, (No Diagnostic Substances)